Lonza Adds High-Potency Capacity

15:56 PM | June 20, 2007 | Chemical Week Editorial Staff

Lonza says it will build a plant at Visp, Switzerland to produce high-potency active pharmaceutical ingredients at large scale. The facility, which is due to cost SF80 million ($64 million), is...